Sept 12: Probing the Legal Arguments in the Drug Industry's Challenges to Medicare Drug Price Negotiations
With the Biden administration’s recent announcement of the first 10 drugs to be negotiated for Medicare as part of the Inflation Reduction Act (IRA), an array of legal challenges from the pharmaceutical industry is potentially the biggest obstacle to implementation. In court filings, individual drugmakers and the industry’s main lobbying group contend that the negotiations<span class="readmore-ellipsis">…</span><a href="https://www.kff.org/medicare/event/sept-12-probing-the-legal-arguments-in-the-drug-industrys-challenges-to-medicare-drug-price-negotiat...